EY Announces the Acquisition of Aqurance to Accelerate Life Science Transformation on Veeva Technology
October 14, 2025
October 14, 2025
NEW YORK, Oct. 14 -- Ernst and Young, an assurance, tax, transaction and advisory service, presented the following news release on Oct. 13, 2025:
* * *
EY announces the acquisition of Aqurance to accelerate life science transformation on Veeva technology
* Acquisition aims to strengthen the EY organization's Veeva Centers of Excellence, expanding clinical, regulatory and commercial services capabilities for global pharma and biotech.
*
* * *
EY announces the acquisition of Aqurance to accelerate life science transformation on Veeva technology
* Acquisition aims to strengthen the EY organization's Veeva Centers of Excellence, expanding clinical, regulatory and commercial services capabilities for global pharma and biotech.
*
